⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2297156 | 0.86 | CTSK (0.32) | — | |
| SCHEMBL2298122 | 0.81 | — | — | |
| SCHEMBL2294019 | 0.78 | ALDH1A1 (0.36) | — | |
| SCHEMBL2294529 | 0.76 | GLB1 (0.33) | — | |
| SCHEMBL23681046 | 0.73 | — | — | |
| SCHEMBL2297989 | 0.72 | — | — | |
| SCHEMBL3311378 | 0.72 | — | — | |
| SCHEMBL2296486 | 0.69 | — | — | |
| SCHEMBL2299850 | 0.69 | — | — | |
| SCHEMBL2299229 | 0.68 | KDM4E (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7999006-B2 | Anticancer agents; mitogen-activated protein kinases (MEK) | EXELIXIS, INC. (US) | 2011-08-16 | — | — | US | claimed |